Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05285566 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pain Control for Undergoing Costal Cartilage Harvesting

StatusRecruiting
PhasePhase 4
Started2022-05-04
View on ClinicalTrials.gov ↗

Amendment history

2026-09-08
Study Status v6
Completion pushed: 2026-09 → 2027-09
Primary completion dateestimated 2026-08→confirmed 2026-08-21
2025-09-10
Study Status, Contacts/Locations v5
Primary completion date2025-08→2026-08
Completion date2025-09→2026-09
Study sitescontacts updated at 1 of 1 site
2024-09-30
Study Status v4
Primary completion date2024-08→2025-08
Completion date2024-09→2025-09
2024-06-06
Study Status, References v3
Primary completion date2024-05→2024-08
Completion date2024-05→2024-09
2023-05-24
Study Status v2
Primary completion date2023-05-01→2024-05
Completion date2024-05-01→2024-05
2022-06-11
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2022-05-01→confirmed 2022-05-04
Study sitesdetails revised at 1 of 1 site
2022-03-09
Original filing
Mayo Clinic
1,015 trials monitored
See 115 trials at risk
The purpose of this study is to find out whether injecting the U.S. Food and Drug Administration (FDA) approved drug EXPAREL®, a long acting (approximately 96 hours) numbing medication, will reduce pain after rib cartilage removal in comparison to the standard injection of XYLOCAINE®.
Trial Details
NCT Number NCT05285566
Lead Sponsor Mayo Clinic
Conditions Nasal Surgery
Enrollment 60 participants
Start Date 2022-05-04
Primary Completion 2026-08-21 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-09-11